Neuroendocrine gastroenteropancreatic tumours (GEP-NET) constitute a heterogeneous
group of tumours with their origin in neuroendocrine cells of the embryological gut, most …

Pancreatic neuroendocrine tumors (pNETs) comprise with gastrointestinal carcinoids, the
main groups of gastrointestinal neuroendocrine tumors (GI-NETs). Although these two …

Neuroendocrine tumors (NETs) of the digestive tract are a heterogeneous group of rare
malignancies. Three major subgroups can be defined: pancreatic endocrine tumors …

Neuroendocrine tumors (NET) are classified according to the Ki67 in low-intermediate grade
(Ki67< 20%) and high grade (Ki67> 20%). The NET of the latter group are also known as …

4004 Background: Patients with advanced pancreatic neuroendocrine tumors (pNETs) have
few treatment options that yield objective tumor regression. Somatostatin analogues …

Gastroenteropancreatic neuroendocrine neoplasia (GEPNEN) comprises clinically as well
as prognostically diverse tumour entities often diagnosed at late stage. Current classification …

Opinion statement Neuroendocrine tumors (NETs) are a heterogeneous group of
malignancies characterized by variable but most often indolent biologic behavior. Well …

Background Platinum‐based chemotherapy is recommended for the treatment of advanced
gastroenteropancreatic neuroendocrine carcinoma (GEP‐NEC). The objective of the current …

Aim of the study Gastro-intestinal neuroendocrine tumours (GI-NETs) are chemotherapy-
resistant tumours. Bevacizumab, an inhibitor of vascular endothelial growth factor (VEGF) …

Despite similar histological and morphological aspects, gastro-enteropancreatic (GEP)
endocrine tumours represent a heterogeneous group of tumours with varying clinical …